| Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa JRC Pulliam, C van Schalkwyk, N Govender, A von Gottberg, C Cohen, ... Science 376 (6593), eabn4947, 2022 | 891 | 2022 |
| Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022 | 816 | 2022 |
| Effectiveness of BNT162b2 vaccine against omicron variant in South Africa S Collie, J Champion, H Moultrie, LG Bekker, G Gray New England Journal of Medicine 386 (5), 494-496, 2022 | 632 | 2022 |
| Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children A Violari, JC Lindsey, MD Hughes, HA Mujuru, L Barlow-Mosha, ... New England Journal of Medicine 366 (25), 2380-2389, 2012 | 228 | 2012 |
| The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV LF Johnson, K Stinson, ML Newell, RM Bland, H Moultrie, MA Davies, ... Journal of acquired immune deficiency syndromes (1999) 59 (4), 417, 2012 | 169 | 2012 |
| Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration MA Davies, O Keiser, B Eley, H Rabie, G van Cutsem, J Giddy, R Wood, ... South African medical journal 99 (10), 2009 | 157 | 2009 |
| Virologic failure and second-line antiretroviral therapy in children in South Africa—the IeDEA Southern Africa collaboration MA Davies, H Moultrie, B Eley, H Rabie, G Van Cutsem, J Giddy, R Wood, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (3), 270-278, 2011 | 147 | 2011 |
| Challenges to pediatric HIV care and treatment in South Africa T Meyers, H Moultrie, K Naidoo, M Cotton, B Eley, G Sherman The Journal of infectious diseases 196 (Supplement_3), S474-S481, 2007 | 144 | 2007 |
| Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... MedRxiv, 2021.12. 21.21268116, 2021 | 128 | 2021 |
| Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa L Fenner, MWG Brinkhof, O Keiser, R Weigel, M Cornell, H Moultrie, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 54 (5), 524-532, 2010 | 117 | 2010 |
| HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort NA Martinson, H Moultrie, R Van Niekerk, G Barry, A Coovadia, M Cotton, ... The International journal of tuberculosis and lung disease 13 (7), 862-867, 2009 | 98 | 2009 |
| The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions K Dheda, T Perumal, H Moultrie, R Perumal, A Esmail, AJ Scott, ... The Lancet Respiratory Medicine 10 (6), 603-622, 2022 | 89 | 2022 |
| The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis LF Johnson, MA Davies, H Moultrie, GG Sherman, RM Bland, TM Rehle, ... The Pediatric infectious disease journal 31 (5), 474-480, 2012 | 78 | 2012 |
| Effectiveness of Ad26. COV2. S and BNT162b2 vaccines against Omicron variant in South Africa G Gray, S Collie, A Goga, N Garrett, J Champion, I Seocharan, L Bamford, ... New England Journal of Medicine 386 (23), 2243-2245, 2022 | 71 | 2022 |
| Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa TM Meyers, M Yotebieng, L Kuhn, H Moultrie The Pediatric infectious disease journal 30 (11), 974-979, 2011 | 71 | 2011 |
| Monitoring the South African national antiretroviral treatment programme, 2003-2007: the IeDEA Southern Africa collaboration M Cornell, K Technau, L Fairall, R Wood, H Moultrie, G Van Cutsem, ... South African Medical Journal 99 (9), 2009 | 68 | 2009 |
| Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy CT Yiannoutsos, LF Johnson, A Boulle, BS Musick, T Gsponer, E Balestre, ... Sexually transmitted infections 88 (Suppl 2), i33-i43, 2012 | 67 | 2012 |
| Changing the South African national antiretroviral therapy guidelines: the role of cost modelling G Meyer-Rath, LF Johnson, Y Pillay, M Blecher, AT Brennan, L Long, ... PLoS One 12 (10), e0186557, 2017 | 65 | 2017 |
| Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype HM McIlleron, M Schomaker, Y Ren, P Sinxadi, JJC Nuttall, H Gous, ... AIDS (London, England) 27 (12), 1933, 2013 | 65 | 2013 |
| Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1–infected children aged 2 through 18 years S Nachman, N Zheng, EP Acosta, H Teppler, B Homony, B Graham, ... Clinical infectious diseases 58 (3), 413-422, 2014 | 62 | 2014 |
